TokenPost topic

Halozyme Therapeutics

1 TokenPost story is tagged Halozyme Therapeutics. The newest appear first.

Latest Halozyme Therapeutics stories

• Halozyme Therapeutics Raises 2026 Revenue Outlook After Q3 Beat

  Third-quarter revenue rose 39% year over year to $493 million, while non-GAAP earnings per share reached $2.39, 3 cents above estimates.

  Nov 7, 2026, 6:12 AM EST · Business